P13631 (RARG_HUMAN) Homo sapiens (Human)
Retinoic acid receptor gamma UniProtKBInterProSTRINGInteractive Modelling
Available Structures
11 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure-based design of Trifarotene (CD5789), a potent and selective RAR gamma agonist for the tr… | monomer | 1×E9T; 1×PG4; | ||||
| Assess | ||||||
| LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO ALL-TRANS RETINOIC ACID | monomer | 1×REA; | ||||
| Assess | ||||||
| LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO 9-CIS RETINOIC ACID | monomer | 1×9CR; | ||||
| Assess | ||||||
| LIGAND-BINDING DOMAIN OF THE HUMAN RETINOIC ACID RECEPTOR GAMMA BOUND TO THE SYNTHETIC AGONIST BMS9… | monomer | 1×961; | ||||
| Assess | ||||||
| ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARBETA/… | monomer | 1×564; 1×LMU; | ||||
| Assess | ||||||
| ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRA… | monomer | 1×394; 1×LMU; | ||||
| Assess | ||||||
| ENANTIOMER DISCRIMINATION ILLUSTRATED BY CRYSTAL STRUCTURES OF THE HUMAN RETINOIC ACID RECEPTOR HRA… | monomer | 1×961; 1×LMU; | ||||
| Assess | ||||||
| RARg mutant-S371E | monomer | 1×9CR; 1×LMU; 1×CL; | ||||
| Assess | ||||||
| ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA… | monomer | 1×254; 1×LMU; | ||||
| Assess | ||||||
| ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE PANAGONI… | monomer | 1×156; 1×LMU; | ||||
| Assess | ||||||
| ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: THE COMPLEX WITH THE RARGAMMA… | monomer | 1×184; 1×LMU; | ||||
| Assess | ||||||
12 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5uan.1.B | monomer | 0.81 | 2×ZN; | 85.26 | ||
| Assess | ||||||
| 4nqa.1.B | monomer | 0.65 | 1×ZN; | 34.93 | ||
| Assess | ||||||
| 4nqa.2.B | monomer | 0.65 | 2×ZN; | 34.93 | ||
| Assess | ||||||
| 4iqr.2.A | monomer | 0.62 | 2×ZN; | 28.53 | ||
| Assess | ||||||
| 5uan.1.A | monomer | 0.61 | 1×ZN; | 33.23 | ||
| Assess | ||||||
| 3dzy.1.A | monomer | 0.61 | 2×ZN; | 32.93 | ||
| Assess | ||||||
| 4nqa.1.A | monomer | 0.60 | 2×ZN; | 33.23 | ||
| Assess | ||||||
| 4iqr.2.B | monomer | 0.60 | 2×ZN; | 28.53 | ||
| Assess | ||||||
| 3dzy.1.B | monomer | 0.59 | 1×ZN; | 36.00 | ||
| Assess | ||||||
| 7prw.1.A | monomer | 0.58 | 2×ZN; | 21.13 | ||
| Assess | ||||||
| 7kw7.1.F | monomer | 0.57 | 21.43 | |||
| Assess | ||||||
| 7prv.1.B | monomer | 0.57 | 2×ZN; | 21.13 | ||
| Assess | ||||||
35 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 5uan.1.B | monomer | 0.80 | 2×ZN; | 85.76 | |
| Assess | ||||||
| Isoform 2 | 4nqa.1.B | monomer | 0.65 | 1×ZN; | 35.03 | |
| Assess | ||||||
| Isoform 2 | 4nqa.2.B | monomer | 0.65 | 2×ZN; | 35.03 | |
| Assess | ||||||
| Isoform 2 | 4iqr.2.A | monomer | 0.61 | 2×ZN; | 28.44 | |
| Assess | ||||||
| Isoform 2 | 3dzy.1.A | monomer | 0.61 | 2×ZN; | 32.93 | |
| Assess | ||||||
| Isoform 2 | 5uan.1.A | monomer | 0.61 | 1×ZN; | 33.23 | |
| Assess | ||||||
| Isoform 2 | 4nqa.1.A | monomer | 0.60 | 2×ZN; | 33.23 | |
| Assess | ||||||
| Isoform 2 | 4iqr.2.B | monomer | 0.60 | 2×ZN; | 28.44 | |
| Assess | ||||||
| Isoform 2 | 3dzy.1.B | monomer | 0.59 | 1×ZN; | 36.00 | |
| Assess | ||||||
| Isoform 2 | 7prw.1.A | monomer | 0.57 | 2×ZN; | 21.13 | |
| Assess | ||||||
| Isoform 2 | 7prw.1.B | monomer | 0.57 | 2×ZN; | 21.13 | |
| Assess | ||||||
| Isoform 2 | 7kw7.1.F | monomer | 0.57 | 21.49 | ||
| Assess | ||||||
| Isoform 3 | 5uan.1.B | monomer | 0.81 | 2×ZN; | 85.01 | |
| Assess | ||||||
| Isoform 3 | 4nqa.1.B | monomer | 0.66 | 1×ZN; | 35.69 | |
| Assess | ||||||
| Isoform 3 | 4nqa.2.B | monomer | 0.64 | 2×ZN; | 35.69 | |
| Assess | ||||||
| Isoform 3 | 4iqr.2.A | monomer | 0.62 | 2×ZN; | 28.57 | |
| Assess | ||||||
| Isoform 3 | 5uan.1.A | monomer | 0.61 | 1×ZN; | 33.23 | |
| Assess | ||||||
| Isoform 3 | 3dzy.1.A | monomer | 0.61 | 2×ZN; | 32.93 | |
| Assess | ||||||
| Isoform 3 | 4nqa.2.A | monomer | 0.60 | 1×ZN; | 33.23 | |
| Assess | ||||||
| Isoform 3 | 4iqr.2.B | monomer | 0.60 | 2×ZN; | 28.57 | |
| Assess | ||||||
| Isoform 3 | 3dzy.1.B | monomer | 0.59 | 1×ZN; | 36.00 | |
| Assess | ||||||
| Isoform 3 | 7prw.1.A | monomer | 0.58 | 2×ZN; | 21.13 | |
| Assess | ||||||
| Isoform 3 | 7prv.1.B | monomer | 0.57 | 2×ZN; | 21.13 | |
| Assess | ||||||
| Isoform 3 | 7kw7.1.F | monomer | 0.56 | 21.49 | ||
| Assess | ||||||
| Isoform 4 | 5uan.1.B | monomer | 0.74 | 1×ZN; | 78.78 | |
| Assess | ||||||
| Isoform 4 | 4nqa.2.B | monomer | 0.64 | 1×ZN; | 31.44 | |
| Assess | ||||||
| Isoform 4 | 4nqa.1.B | monomer | 0.63 | 31.44 | ||
| Assess | ||||||
| Isoform 4 | 4iqr.2.A | monomer | 0.58 | 1×ZN; | 25.86 | |
| Assess | ||||||
| Isoform 4 | 3dzy.1.A | monomer | 0.57 | 1×ZN; | 29.27 | |
| Assess | ||||||
| Isoform 4 | 4nqa.2.A | monomer | 0.57 | 29.04 | ||
| Assess | ||||||
| Isoform 4 | 5uan.1.A | monomer | 0.56 | 29.04 | ||
| Assess | ||||||
| Isoform 4 | 4iqr.2.B | monomer | 0.56 | 1×ZN; | 25.86 | |
| Assess | ||||||
| Isoform 4 | 7kw7.1.F | monomer | 0.55 | 18.51 | ||
| Assess | ||||||
| Isoform 4 | 7prw.1.A | monomer | 0.55 | 1×ZN; | 18.40 | |
| Assess | ||||||
| Isoform 4 | 7prw.1.B | monomer | 0.55 | 1×ZN; | 18.40 | |
| Assess | ||||||